The ability of GLP-1 agonists to accelerate preoperative weight loss without increasing complications could possibly increase patient retention in hernia programs, enabling more patients to reach surgery than otherwise possible with lifestyle modifications alone. The gene discussed is GLP1R; the disease is Hernia.